Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
abbvie
allergan
amgen
bempedoic acid
bial
biohaven
cgpr
cholesterol
corticosteroids
detroit
detroit blog main
detroit top stories
drug development
eli lilly
esperion therapeutics
europe blog main
ezetimibe
fluoroquinolones
merck
migraine
national
national top stories
neurocrine
neurodegeneration
neuroscience
new york blog main
opicapone
parkinson's disease
san diego
san diego blog main
san diego top stories
statins
tim mayleben
What
fda
nod
3
×
pill
3
×
approved
medicines
wins
add
adults
allergan
called
carbidopa
cholesterol
class
combination
combo
control
daily
disease
drug
esperion
esperion’s
experience
gets
levels
levodopa
lowering
medication
migraine
monday
neurocrine
new
pairs
parkinson’s
patients
regulatory
second
single
symptoms
therapeutics
time
Language
unset
Current search:
nod
×
pill
×
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
